{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:30:19Z","timestamp":1790134219445,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,25]]},"DOI":"10.7759\/cureus.59009","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T17:40:56Z","timestamp":1714066856000},"source":"Crossref","is-referenced-by-count":10,"title":["C-reactive Protein: An Inflammatory Biomarker and a Predictor of Neurodegenerative Disease in Patients With Inflammatory Bowel Disease?"],"prefix":"10.7759","author":[{"given":"Simona","family":"Muresan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Slevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000527846","article-title":"Positioning and usefulness of biomarkers in inflammatory bowel disease","volume":"104","author":"Sakurai T","year":"2023","unstructured":"Sakurai T, Saruta M. Positioning and usefulness of biomarkers in inflammatory bowel disease. Digestion. 2023, 104:30-41. 10.1159\/000527846","journal-title":"Digestion"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000511641","article-title":"Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches?","volume":"39","author":"Dragoni G","year":"2021","unstructured":"Dragoni G, Innocenti T, Galli A. Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches?. Dig Dis. 2021, 39:190-203. 10.1159\/000511641","journal-title":"Dig Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2017.400","article-title":"Changing treatment paradigms for the management of inflammatory bowel disease","volume":"33","author":"Im JP","year":"2018","unstructured":"Im JP, Ye BD, Kim YS, Kim JS. Changing treatment paradigms for the management of inflammatory bowel disease. Korean J Intern Med. 2018, 33:28-35. 10.3904\/kjim.2017.400","journal-title":"Korean J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.005","article-title":"Advances in use of endoscopy, radiology, and biomarkers to monitor inflammatory bowel diseases","volume":"152","author":"Panes J","year":"2017","unstructured":"Panes J, Jairath V, Levesque BG. Advances in use of endoscopy, radiology, and biomarkers to monitor inflammatory bowel diseases. Gastroenterology. 2017, 152:362-373.e3. 10.1053\/j.gastro.2016.10.005","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy195","article-title":"The role of biomarkers in clinical trials of inflammatory bowel disease","volume":"24","author":"Khanna R","year":"2018","unstructured":"Khanna R, Narula N, Feagan BG. The role of biomarkers in clinical trials of inflammatory bowel disease. Inflamm Bowel Dis. 2018, 24:1619-23. 10.1093\/ibd\/izy195","journal-title":"Inflamm Bowel Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v6.i1.13","article-title":"Laboratory markers in ulcerative colitis: current insights and future advances","volume":"6","author":"Cioffi M","year":"2015","unstructured":"Cioffi M, Rosa AD, Serao R, Picone I, Vietri MT. Laboratory markers in ulcerative colitis: current insights and future advances. World J Gastrointest Pathophysiol. 2015, 6:13-22. 10.4291\/wjgp.v6.i1.13","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05058-1","article-title":"Predictive biomarkers for anti-TNF alpha therapy in IBD patients","volume":"22","author":"Kumar M","year":"2024","unstructured":"Kumar M, Murugesan S, Ibrahim N, Elawad M, Al Khodor S. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. J Transl Med. 2024, 22:284. 10.1186\/s12967-024-05058-1","journal-title":"J Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac076","article-title":"Accuracy of serum leucine-rich alpha-2 glycoprotein in evaluating endoscopic disease activity in Crohn\u2019s disease","volume":"29","author":"Kawamura T","year":"2023","unstructured":"Kawamura T, Yamamura T, Nakamura M, et al.. Accuracy of serum leucine-rich alpha-2 glycoprotein in evaluating endoscopic disease activity in Crohn\u2019s disease. Inflamm Bowel Dis. 2023, 29:245-53. 10.1093\/ibd\/izac076","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1204727","article-title":"Association between inflammatory bowel disease and risk of stroke: a systematic review and meta-analysis of cohort studies","volume":"14","author":"Fan JS","year":"2023","unstructured":"Fan JS, Wang M, Chen N, Sun BC, Zhang QB, Li Y, Huang MJ. Association between inflammatory bowel disease and risk of stroke: a systematic review and meta-analysis of cohort studies. Front Neurol. 2023, 14:1204727. 10.3389\/fneur.2023.1204727","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.01.022","article-title":"Dementia","volume":"131","author":"Gale SA","year":"2018","unstructured":"Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018, 131:1161-9. 10.1016\/j.amjmed.2018.01.022","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.962681","article-title":"Inflammatory bowel disease and risk of dementia: an updated meta-analysis","volume":"14","author":"Liu N","year":"2022","unstructured":"Liu N, Wang Y, He L, Sun J, Wang X, Li H. Inflammatory bowel disease and risk of dementia: an updated meta-analysis. Front Aging Neurosci. 2022, 14:962681. 10.3389\/fnagi.2022.962681","journal-title":"Front Aging Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4593","article-title":"Inflammatory bowel disease and patients with mental disorders: what do we know?","volume":"13","author":"Fousekis FS","year":"2021","unstructured":"Fousekis FS, Katsanos AH, Kourtis G, Saridi M, Albani E, Katsanos KH, Christodoulou DK. Inflammatory bowel disease and patients with mental disorders: what do we know?. J Clin Med Res. 2021, 13:466-73. 10.14740\/jocmr4593","journal-title":"J Clin Med Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007094","article-title":"Systemic inflammation during midlife and cognitive change over 20 years: the ARIC study","volume":"92","author":"Walker KA","year":"2019","unstructured":"Walker KA, Gottesman RF, Wu A, et al.. Systemic inflammation during midlife and cognitive change over 20 years: the ARIC study. Neurology. 2019, 92:e1256-67. 10.1212\/WNL.0000000000007094","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320789","article-title":"Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study","volume":"70","author":"Zhang B","year":"2021","unstructured":"Zhang B, Wang HE, Bai YM, et al.. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021, 70:85-91. 10.1136\/gutjnl-2020-320789","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5009\/gnl220523","article-title":"Inflammatory bowel disease and neurodegenerative diseases","volume":"17","author":"Kim JS","year":"2023","unstructured":"Kim JS, Chen MH, Wang HE, Lu CL, Wang YP, Zhang B. Inflammatory bowel disease and neurodegenerative diseases. Gut Liver. 2023, 17:495-504. 10.5009\/gnl220523","journal-title":"Gut Liver"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-022-02076-1","article-title":"Inflammatory bowel disease as a new risk factor for dementia","volume":"34","author":"Zuin M","year":"2022","unstructured":"Zuin M, De Giorgio R, Capatti E, Boschetti E, Zuliani G. Inflammatory bowel disease as a new risk factor for dementia. Aging Clin Exp Res. 2022, 34:1725-8. 10.1007\/s40520-022-02076-1","journal-title":"Aging Clin Exp Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1087571","article-title":"A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia","volume":"14","author":"Cooper J","year":"2023","unstructured":"Cooper J, Pastorello Y, Slevin M. A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia. Front Immunol. 2023, 14:1087571. 10.3389\/fimmu.2023.1087571","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1082575","article-title":"Association of inflammatory bowel disease and related medication exposure with risk of Alzheimer's disease: an updated meta-analysis","volume":"14","author":"Xing Y","year":"2022","unstructured":"Xing Y, Li P, Jia Y, Zhang K, Liu M, Jiang J. Association of inflammatory bowel disease and related medication exposure with risk of Alzheimer's disease: an updated meta-analysis. Front Aging Neurosci. 2022, 14:1082575. 10.3389\/fnagi.2022.1082575","journal-title":"Front Aging Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416199","article-title":"Relationship of cognition and Alzheimer\u2019s disease with gastrointestinal tract disorders: a large-scale genetic overlap and Mendelian randomisation analysis","volume":"23","author":"Adewuyi EO","year":"2022","unstructured":"Adewuyi EO, O'Brien EK, Porter T, Laws SM. Relationship of cognition and Alzheimer\u2019s disease with gastrointestinal tract disorders: a large-scale genetic overlap and Mendelian randomisation analysis. Int J Mol Sci. 2022, 23:16199. 10.3390\/ijms232416199","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110610","article-title":"Inflammatory bowel disease: a potential pathogenic factor of Alzheimer's disease","volume":"119","author":"Wang D","year":"2022","unstructured":"Wang D, Zhang X, Du H. Inflammatory bowel disease: a potential pathogenic factor of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2022, 119:110610. 10.1016\/j.pnpbp.2022.110610","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.10575","article-title":"Association of midlife to late-life blood pressure patterns with incident dementia","volume":"322","author":"Walker KA","year":"2019","unstructured":"Walker KA, Sharrett AR, Wu A, et al.. Association of midlife to late-life blood pressure patterns with incident dementia. JAMA. 2019, 322:535-45. 10.1001\/jama.2019.10575","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13911","article-title":"A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease","volume":"32","author":"Sinniger V","year":"2020","unstructured":"Sinniger V, Pellissier S, Fauvelle F, et al.. A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterol Motil. 2020, 32:e13911. 10.1111\/nmo.13911","journal-title":"Neurogastroenterol Motil"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16755","article-title":"Electroacupuncture at ST 36 ameliorates cognitive impairment and beta-amyloid pathology by inhibiting NLRP3 inflammasome activation in an Alzheimer's disease animal model","volume":"9","author":"Ni H","year":"2023","unstructured":"Ni H, Ren J, Wang Q, Li X, Wu Y, Liu D, Wang J. Electroacupuncture at ST 36 ameliorates cognitive impairment and beta-amyloid pathology by inhibiting NLRP3 inflammasome activation in an Alzheimer's disease animal model. Heliyon. 2023, 9:e16755. 10.1016\/j.heliyon.2023.e16755","journal-title":"Heliyon"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1113\/JP279919","article-title":"Intra-gastrointestinal amyloid-\u03b21-42 oligomers perturb enteric function and induce Alzheimer's disease pathology","volume":"598","author":"Sun Y","year":"2020","unstructured":"Sun Y, Sommerville NR, Liu JY, et al.. Intra-gastrointestinal amyloid-\u03b21-42 oligomers perturb enteric function and induce Alzheimer's disease pathology. J Physiol. 2020, 598:4209-23. 10.1113\/JP279919","journal-title":"J Physiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106844","article-title":"Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review)","volume":"208","author":"Wang H","year":"2021","unstructured":"Wang H, Liu Y, Zhao J, Guo X, Hu M, Chen Y. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review). Clin Neurol Neurosurg. 2021, 208:106844. 10.1016\/j.clineuro.2021.106844","journal-title":"Clin Neurol Neurosurg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2011.12.007","article-title":"Promotion of \u03b2-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease","volume":"60","author":"Bi BT","year":"2012","unstructured":"Bi BT, Lin HB, Cheng YF, et al.. Promotion of \u03b2-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease. Neurochem Int. 2012, 60:257-66. 10.1016\/j.neuint.2011.12.007","journal-title":"Neurochem Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/srep13281","article-title":"Monomeric C-reactive protein - a key molecule driving development of Alzheimer's disease associated with brain ischaemia?","volume":"5","author":"Slevin M","year":"2015","unstructured":"Slevin M, Matou S, Zeinolabediny Y, et al.. Monomeric C-reactive protein - a key molecule driving development of Alzheimer's disease associated with brain ischaemia?. Sci Rep. 2015, 5:13281. 10.1038\/srep13281","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00430","article-title":"C-reactive protein in atherothrombosis and angiogenesis","volume":"9","author":"Badimon L","year":"2018","unstructured":"Badimon L, Pe\u00f1a E, Arderiu G, Padr\u00f3 T, Slevin M, Vilahur G, Chiva-Blanch G. C-reactive protein in atherothrombosis and angiogenesis. Front Immunol. 2018, 9:430. 10.3389\/fimmu.2018.00430","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"10","author":"Vermeire S","year":"2004","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004, 10:661-5. 10.1097\/00054725-200409000-00026","journal-title":"Inflamm Bowel Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae032","article-title":"Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease","author":"Swaminathan A","year":"2024","unstructured":"Swaminathan A, Borichevsky GM, Frampton CM, Day AS, Hampton MB, Kettle AJ, Gearry RB. Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease. Inflamm Bowel Dis. 2024, 10.1093\/ibd\/izae032","journal-title":"Inflamm Bowel Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5604\/17322693.1223798","article-title":"C-reactive protein as a diagnostic and prognostic factor in inflammatory bowel diseases","volume":"70","author":"Ma\u0144kowska-Wierzbicka D","year":"2016","unstructured":"Ma\u0144kowska-Wierzbicka D, Karczewski J, Poniedzia\u0142ek B, et al.. C-reactive protein as a diagnostic and prognostic factor in inflammatory bowel diseases. Postepy Hig Med Dosw (Online). 2016, 70:1124-30. 10.5604\/17322693.1223798","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07178-w","article-title":"Patient-reported outcome and clinical scores are equally accurate in predicting mucosal healing in ulcerative colitis: a prospective study","volume":"67","author":"Golovics PA","year":"2022","unstructured":"Golovics PA, Gonczi L, Reinglas J, et al.. Patient-reported outcome and clinical scores are equally accurate in predicting mucosal healing in ulcerative colitis: a prospective study. Dig Dis Sci. 2022, 67:3089-95. 10.1007\/s10620-021-07178-w","journal-title":"Dig Dis Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/crocol\/otac047","article-title":"Inflammatory response in patients with Crohn\u2019s disease compared with ulcerative colitis: secondary results of a prospective pilot study","volume":"4","author":"El-Hussuna A","year":"2022","unstructured":"El-Hussuna A, Varghese C, Bhat V, Qvist N. Inflammatory response in patients with Crohn\u2019s disease compared with ulcerative colitis: secondary results of a prospective pilot study. Crohns Colitis 360. 2022, 4:otac047. 10.1093\/crocol\/otac047","journal-title":"Crohns Colitis 360"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21933","article-title":"High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?","volume":"18","author":"Kiss LS","year":"2012","unstructured":"Kiss LS, Papp M, Lovasz BD, et al.. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?. Inflamm Bowel Dis. 2012, 18:1647-54. 10.1002\/ibd.21933","journal-title":"Inflamm Bowel Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12227165","article-title":"Biomarkers for monitoring of changes in disease activity in ulcerative colitis","volume":"12","author":"Tatsumi Y","year":"2023","unstructured":"Tatsumi Y, Kakimoto K, Hara A, et al.. Biomarkers for monitoring of changes in disease activity in ulcerative colitis. J Clin Med. 2023, 12:10.3390\/jcm12227165","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13175","article-title":"Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis","volume":"41","author":"Rosen MJ","year":"2015","unstructured":"Rosen MJ, Minar P, Vinks AA. Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis. Aliment Pharmacol Ther. 2015, 41:1094-103. 10.1111\/apt.13175","journal-title":"Aliment Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6722com","article-title":"Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m)","volume":"21","author":"Ji SR","year":"2007","unstructured":"Ji SR, Wu Y, Zhu L, Potempa LA, Sheng FL, Lu W, Zhao J. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J. 2007, 21:284-94. 10.1096\/fj.06-6722com","journal-title":"FASEB J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.968267","article-title":"The monomeric C-reactive protein level is associated with the increase in carotid plaque number in patients with subclinical carotid atherosclerosis","volume":"9","author":"Melnikov I","year":"2022","unstructured":"Melnikov I, Kozlov S, Pogorelova O, et al.. The monomeric C-reactive protein level is associated with the increase in carotid plaque number in patients with subclinical carotid atherosclerosis. Front Cardiovasc Med. 2022, 9:968267. 10.3389\/fcvm.2022.968267","journal-title":"Front Cardiovasc Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12319","article-title":"Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease","volume":"8","author":"Gan Q","year":"2022","unstructured":"Gan Q, Wong A, Zhang Z, et al.. Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease. Alzheimers Dement (N Y). 2022, 8:e12319. 10.1002\/trc2.12319","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9093053","article-title":"Monomeric C-reactive protein aggravates secondary degeneration after intracerebral haemorrhagic stroke and may function as a sensor for systemic inflammation","volume":"9","author":"Slevin M","year":"2020","unstructured":"Slevin M, Garc\u00eda-Lara E, Capitanescu B, et al.. Monomeric C-reactive protein aggravates secondary degeneration after intracerebral haemorrhagic stroke and may function as a sensor for systemic inflammation. J Clin Med. 2020, 9:10.3390\/jcm9093053","journal-title":"J Clin Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.190611","article-title":"Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques","volume":"105","author":"Eisenhardt SU","year":"2009","unstructured":"Eisenhardt SU, Habersberger J, Murphy A, et al.. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res. 2009, 105:128-37. 10.1161\/CIRCRESAHA.108.190611","journal-title":"Circ Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2011.00539.x","article-title":"Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease?","volume":"22","author":"Strang F","year":"2012","unstructured":"Strang F, Scheichl A, Chen YC, et al.. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease?. Brain Pathol. 2012, 22:337-46. 10.1111\/j.1750-3639.2011.00539.x","journal-title":"Brain Pathol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.389640","article-title":"Monomeric C-reactive protein: a link between chronic inflammation and neurodegeneration?","volume":"19","author":"Arnaut N","year":"2024","unstructured":"Arnaut N, Pastorello Y, Slevin M. Monomeric C-reactive protein: a link between chronic inflammation and neurodegeneration?. Neural Regen Res. 2024, 19:1643-4. 10.4103\/1673-5374.389640","journal-title":"Neural Regen Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073088","article-title":"Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions","volume":"8","author":"Leonetti D","year":"2013","unstructured":"Leonetti D, Reimund JM, Tesse A, Viennot S, Martinez MC, Bretagne AL, Andriantsitohaina R. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One. 2013, 8:e73088. 10.1371\/journal.pone.0073088","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02831-9","article-title":"Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity","volume":"24","author":"Karlsson J","year":"2022","unstructured":"Karlsson J, Wetter\u00f6 J, Weiner M, R\u00f6nnelid J, Fernandez-Botran R, Sj\u00f6wall C. Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity. Arthritis Res Ther. 2022, 24:139. 10.1186\/s13075-022-02831-9","journal-title":"Arthritis Res Ther"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13164","article-title":"Monomeric C-reactive protein: a novel biomarker predicting neurodegenerative disease and vascular dysfunction","volume":"33","author":"Pastorello Y","year":"2023","unstructured":"Pastorello Y, Carare RO, Banescu C, Potempa L, Di Napoli M, Slevin M. Monomeric C-reactive protein: a novel biomarker predicting neurodegenerative disease and vascular dysfunction. Brain Pathol. 2023, 33:e13164. 10.1111\/bpa.13164","journal-title":"Brain Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244930-c-reactive-protein-an-inflammatory-biomarker-and-a-predictor-of-neurodegenerative-disease-in-patients-with-inflammatory-bowel-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T17:41:00Z","timestamp":1714066860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244930-c-reactive-protein-an-inflammatory-biomarker-and-a-predictor-of-neurodegenerative-disease-in-patients-with-inflammatory-bowel-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.59009","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}